These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 8578850

  • 21. [Immunity to measles, mumps and rubella in children vaccinated with triple viral vaccine].
    Pisón Garcés FJ, Galbe Sánchez-Ventura J, Arcauz Eguren P, Aguirre y Dabán C, Mengual Gil J, Larrad Mur L.
    Aten Primaria; 1995 Mar 15; 15(4):235-7. PubMed ID: 7703334
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Seroprevalence of antibodies to measles, mumps, and rubella among Thai population: evaluation of measles/MMR immunization programme.
    Tharmaphornpilas P, Yoocharean P, Rasdjarmrearnsook AO, Theamboonlers A, Poovorawan Y.
    J Health Popul Nutr; 2009 Feb 15; 27(1):80-6. PubMed ID: 19248651
    [Abstract] [Full Text] [Related]

  • 25. Response to measles-mumps-rubella vaccine in children on dialysis.
    Schulman SL, Deforest A, Kaiser BA, Polinsky MS, Baluarte HJ.
    Pediatr Nephrol; 1992 Mar 15; 6(2):187-9. PubMed ID: 1571219
    [Abstract] [Full Text] [Related]

  • 26. Antibody response to measles-mumps-rubella vaccine of children with mild illness at the time of vaccination. Should we be concerned?
    Watada B, Kennedy K, Chan D, Church B, Patriquin M, Shariff F, Evans MF.
    Can Fam Physician; 1998 Jan 15; 44():53-5. PubMed ID: 9481462
    [No Abstract] [Full Text] [Related]

  • 27. Seroconversion rates to combined measles-mumps-rubella-varicella vaccine of children with upper respiratory tract infection.
    Dennehy PH, Saracen CL, Peter G.
    Pediatrics; 1994 Oct 15; 94(4 Pt 1):514-6. PubMed ID: 7936862
    [Abstract] [Full Text] [Related]

  • 28. [The immunological efficacy of the combined vaccine Trimovax intended for the prevention of measles, mumps and rubella].
    Samoĭlovich EO, Kapustik LA, Fel'dman EV, Ermolovich MA, Svirchevskaia EIu, Titov LP, Zakharenko DF, Belova EIu, Chernovetskiĭ MA, Korostik TS.
    Zh Mikrobiol Epidemiol Immunobiol; 1998 Oct 15; (4):36-40. PubMed ID: 9783398
    [Abstract] [Full Text] [Related]

  • 29. Antibody response to measles-mumps-rubella vaccine of children with mild illness at the time of vaccination.
    King GE, Markowitz LE, Heath J, Redd SC, Coleman S, Bellini WJ, Sievert A.
    JAMA; 1996 Mar 06; 275(9):704-7. PubMed ID: 8594268
    [Abstract] [Full Text] [Related]

  • 30. Vaccination against measles, mumps and rubella (MMR): a comparison between the antibody responses at the ages of 18 months and 12 years and between different methods of antibody titration.
    Christenson B, Böttiger M.
    J Biol Stand; 1985 Apr 06; 13(2):167-72. PubMed ID: 3997899
    [Abstract] [Full Text] [Related]

  • 31. Immunity to measles before and after MMR booster or primary vaccination at 12 years of age in the first generation offered the 2-dose immunization programme.
    Broliden K, Levén B, Arneborn M, Böttiger M.
    Scand J Infect Dis; 1998 Apr 06; 30(1):23-7. PubMed ID: 9670354
    [Abstract] [Full Text] [Related]

  • 32. Difficulties in eliminating measles and controlling rubella and mumps: a cross-sectional study of a first measles and rubella vaccination and a second measles, mumps, and rubella vaccination.
    Wang Z, Yan R, He H, Li Q, Chen G, Yang S, Chen E.
    PLoS One; 2014 Apr 06; 9(2):e89361. PubMed ID: 24586717
    [Abstract] [Full Text] [Related]

  • 33. The combination measles, mumps, rubella and varicella vaccine in healthy children.
    Arbeter AM, Baker L, Starr SE, Plotkin SA.
    Dev Biol Stand; 1986 Apr 06; 65():89-93. PubMed ID: 3030864
    [Abstract] [Full Text] [Related]

  • 34. Response to measles revaccination among toddlers in Saudi Arabia by the use of two different trivalent measles-mumps-rubella vaccines.
    Khalil M, Poltera AA, al-Howasi M, Herzog C, Gerike E, Wegmüller B, Glück R.
    Trans R Soc Trop Med Hyg; 1999 Apr 06; 93(2):214-9. PubMed ID: 10450452
    [Abstract] [Full Text] [Related]

  • 35. Vaccine-induced measles virus antibodies after two doses of combined measles, mumps and rubella vaccine: a 12-year follow-up in two cohorts.
    Davidkin I, Valle M.
    Vaccine; 1998 Dec 06; 16(20):2052-7. PubMed ID: 9796064
    [Abstract] [Full Text] [Related]

  • 36. [35-year measles, mumps, rubella vaccination assessment in France].
    Reinert P, Soubeyrand B, Gauchoux R.
    Arch Pediatr; 2003 Nov 06; 10(11):948-54. PubMed ID: 14613687
    [Abstract] [Full Text] [Related]

  • 37. Reactogenicity and immunogenicity of a new live attenuated combined measles, mumps and rubella vaccine in healthy children.
    Usonis V, Bakasenas V, Kaufhold A, Chitour K, Clemens R.
    Pediatr Infect Dis J; 1999 Jan 06; 18(1):42-8. PubMed ID: 9951979
    [Abstract] [Full Text] [Related]

  • 38. Low mumps antibody levels induced by mumps-measles-rubella vaccinations in type 1 diabetic children.
    Hiltunen M, Hyöty H, Leinikki P, Akerblom HK, Tuomilehto J, Vesikari T.
    Diabet Med; 1994 Dec 06; 11(10):942-6. PubMed ID: 7895458
    [Abstract] [Full Text] [Related]

  • 39. [Mumps epidemic in vaccinated children in West Switzerland].
    Ströhle A, Eggenberger K, Steiner CA, Matter L, Germann D.
    Schweiz Med Wochenschr; 1997 Jun 28; 127(26):1124-33. PubMed ID: 9312835
    [Abstract] [Full Text] [Related]

  • 40. Measles, mumps and rubella immunisation in children at risk of infection with human immunodeficiency virus.
    Molyneaux PJ, Mok JY, Burns SM, Yap PL.
    J Infect; 1993 Nov 28; 27(3):251-3. PubMed ID: 8308316
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.